Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Quarterly Trading Statement

21 Sep 2011 07:00

RNS Number : 5843O
Standard Life Euro Pri Eqty Tst PLC
21 September 2011
 



 

 

Standard Life European Private Equity Trust PLC

 

 

Investment update for the quarter ended 30 June 2011

 

·; NAV increased by 8.8% to 242.5p for the quarter ended 30 June 2011

·; NAV increased by 24.2% for the first nine months of the current financial year starting 1 October 2010

·; During the quarter the portfolio rose in value by £17.0 million (4.7% of NAV) on a constant exchange rate basis; in addition, unrealised foreign exchange gains on the portfolio were £6.5 million (1.8% of NAV). Realised gains and income were £10.6 million (2.9% of NAV)

·; 100% by value of the portfolio was valued by the respective underlying managers at 30 June 2011

·; Outstanding commitments were £144.5 million at 30 June 2011

·; Net indebtedness was £45.1 million at 30 June 2011

 

For the quarter ended 30 June 2011 the Company's net asset value per ordinary share ("NAV") rose by 8.8% to 242.5p (diluted - 239.4p), from 222.9p (diluted - 220.3p) at 31 March 2011. At 30 June 2011 the Company's net assets were £391.7 million (31 March 2011 - £360.1 million).

 

The European private equity market grew in Q2 2011, with the enterprise value of all transactions reported during the quarter rising to €27.3 billion, up from €13.8 billion in Q1 2011 and €14.3 billion in the equivalent Q2 in 2010. Activity was most pronounced in the mid and large market segments of the European buy-out market.

 

The closing value of the Company's portfolio of 38 private equity fund interests was £436.3 million at 30 June 2011 (31 March 2011 - £410.9 million). Total net unrealised gains for the quarter ended 30 June 2011 were £23.5 million, of which £17.0 million comprised unrealised gains on a constant exchange rate basis and £6.5 million were unrealised foreign exchange gains. The uplift in the portfolio on a constant exchange rate basis continued to reflect strong earnings growth at many underlying investee companies, against a background of broadly flat listed equity markets over the quarter.

 

The Company funded £7.4 million of draw downs (six months ended 31 March 2011 - £29.0 million) and received £16.1 million of distributions (six months ended 31 March 2011 - £36.9 million) during the quarter. The distributions received generated £10.6 million of realised gains and income, which is equivalent to a return of 2.9 times the acquisition cost of the realised investments.

 

The Company made one new private equity fund commitment during the quarter, committing €30.0 million to Montagu IV. The Company had total outstanding commitments to its private equity fund interests of £144.5 million at 30 June 2011 (31 March 2011 - £123.0 million).

 

At 30 June 2011 the Company had net indebtedness of £45.1 million (31 March 2011 - net indebtedness of £51.4 million).

 

During the period from 30 June 2011 to 20 September 2011 the Company funded £10.3 million of draw downs and received £21.4 million of distributions. At 20 September 2011 the Company's total outstanding commitments and net indebtedness were £130.3 million and £33.8 million respectively. No new fund commitments were made in the period from 30 June 2011 to 20 September 2011.

 

It is anticipated that the Company will release its preliminary announcement for the financial year ending 30 September 2011 on or around 5 December 2011. In preparing the valuation of the Company's private equity fund interests at 30 September 2011, the Board is mindful of the movement and volatility in listed financial markets since 30 June 2011 and the need to review in detail the valuations received from underlying managers.

 

 

 

For further information please contact:-

 

Peter McKellar of SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under section 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTXBLFLFKFXBBL
Date   Source Headline
12th Feb 20217:00 amRNSEstimated NAV at 31 January 2021
5th Feb 202112:17 pmRNSDoc re. Annual Report
2nd Feb 20215:28 pmRNSDirector/PDMR Shareholding
26th Jan 20217:05 amRNSEstimated NAV at 31 December 2020
26th Jan 20217:00 amRNSAnnual Financial Report
5th Jan 20214:00 pmRNSQuarterly disclosure
22nd Dec 20204:30 pmRNSREPLACEMENT: Dividend Declaration
14th Dec 20203:01 pmRNSEstimated NAV at 30 November
14th Dec 20203:01 pmRNSFourth Interim Dividend
13th Nov 20207:00 amRNSEstimated NAV at 31 October 2020
12th Nov 20203:26 pmRNSDirector/PDMR Shareholding
5th Nov 20208:31 amRNSEdison review on Standard Life Private Equity Trst
3rd Nov 202012:33 pmRNSDirector/PDMR Shareholding
3rd Nov 20207:02 amRNSDirector Declaration
14th Oct 20207:00 amRNSEstimated NAV at 30 September 2020
2nd Oct 20204:28 pmRNSQuarterly disclosure
30th Sep 20207:02 amRNSEstimate Net Asset Value at 31 August 2020
30th Sep 20207:00 amRNSQuarterly Investment Update at 30 June 2020
24th Sep 20207:00 amRNSIncrease of Loan Facility
8th Sep 202012:21 pmRNSEdison review on Standard Life Private Equity Trst
3rd Sep 202011:08 amRNSThird Interim Dividend
14th Aug 20207:00 amRNSEstimated NAV at 31 July 2020
13th Aug 202010:20 amRNSDirector/PDMR Shareholding
6th Aug 20203:04 pmRNSDirector/PDMR Shareholding
15th Jul 20202:10 pmRNSUpdate research from QuotedData
14th Jul 20207:00 amRNSEstimated NAV at 30 June 2020
2nd Jul 20204:43 pmRNSQuarterly disclosure
26th Jun 20207:00 amRNSHalf-Yearly Report
18th Jun 20207:05 amRNSEstimated NAV at 31 May 2020
18th Jun 20207:00 amRNSHalf-year Report
15th May 20207:00 amRNSEstimated Net Asset Value at 30 April 2020
12th May 20204:07 pmRNSHolding(s) in Company
11th May 202012:14 pmRNSGlobal Macro Review – May 2020
28th Apr 20204:20 pmRNSDisclosure of Rights Attaching to Equity Shares
28th Apr 20203:35 pmRNSDirector/PDMR Shareholding
28th Apr 202011:52 amRNSDirector/PDMR Shareholding
24th Apr 20207:02 amRNSEstimated Net Asset Value at 31 March 2020
24th Apr 20207:00 amRNSQuarterly Investment Update at 31 December 2019
3rd Apr 202010:22 amRNSQuarterly Disclosure
13th Mar 20207:00 amRNSMonth End Net Asset Value(s)
11th Mar 20201:59 pmRNSReal Estate Roundup Review – March 2020
9th Mar 20209:52 amRNSDirector Declaration
9th Mar 20207:00 amRNSFirst Interim Dividend
24th Feb 20203:20 pmRNSResult of AGM
14th Feb 20207:00 amRNSMonth End Net Asset Value(s)
13th Feb 202012:37 pmRNSReplacement - Director/PDMR Shareholding
13th Feb 202012:16 pmRNSDirector/PDMR Shareholding
12th Feb 20202:55 pmRNSDirector/PDMR Shareholding
29th Jan 20208:13 amRNSEdison review on Standard Life Private Equity
28th Jan 20204:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.